Navigation Links
Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results
Date:3/10/2011

RICHMOND, Va., March 10, 2011 /PRNewswire/ -- Insmed Inc. (Nasdaq CM: INSMD), a biopharmaceutical company, today reported results for the fourth quarter and full-year ended December 31, 2010.

Key Recent Highlights:

  • Filed Investigational New Drug (IND) Application in February 2011 with the FDA to begin a phase 3 clinical trial for ARIKACE™ (liposomal amikacin for inhalation) in non-TB Mycobacteria (NTM) lung infections.
  • Successfully concluded 72 week phase 2b open-label study for ARIKACE for pseudomonas lung infections in cystic fibrosis (CF) patients.
  • Received positive opinion from European Medicines Agency (EMA) on Company's Pediatric Investigation Plan for ARIKACE in the CF indication.
  • Gained shareholder approval for conversion of preferred stock into common stock and 1:10 reverse stock split.

  • "Following the closure of our transformative business combination in December 2010, we have been aggressively moving forward with the development plan for ARIKACE, our phase 3 compound for pseudomonas lung infections for CF patients, and NTM lung infections," said Timothy Whitten, Insmed's President & CEO.  "We are well underway with the initial preparations and necessary work around these trials and continue to expect to begin accruing patients to the phase 3 trials in both indications in the second half of 2011, with results expected in the first half of 2013."

    Financial ResultsOn March 1, 2011, at a special meeting, our shareholders approved a one for 10 reverse stock split of our common stock, which became effective at 5:00 pm EST on March 2, 2011.  This reverse stock split is reflected in the shares outstanding and earnings per share calculations below.  

    Revenues for the fourth quarter ended December 31, 2010 were $1.3 million, as compared to $2.5 million for the corresponding period in 2009.  The $1.2 million decrease resulted from $0.6 million in lower cost r
    '/>"/>

    SOURCE Insmed Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Insmed to Host Second Quarter 2009 Conference Call
    2. Insmed Announces Addition to the Russell 3000(R) Index
    3. Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
    4. Insmed CEO Resigns Due to Health Concerns
    5. Insmed Announces First Quarter 2009 Financial Results
    6. Insmed Regains NASDAQ Compliance
    7. Insmed to Host First Quarter 2009 Conference Call
    8. Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)
    9. Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
    10. Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
    11. Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... About Bioactive Material Bioactive ... are increasingly becoming popular due to their ability ... having a negative impact on the human health. ... tissue repair materials in surgical procedures. Bioactive materials ... glass-ceramics, and composites. The major end-users of bioactive ...
    (Date:9/23/2014)... France (PRWEB) September 23, 2014 ... of laboratory personnel since 1968 and Burdinola, supplier of ... of a new filtered fume hood. , ... laboratory fume hood, Burdinola will now offer an innovative ... a wide range of chemicals, best-in-class detection technology, and ...
    (Date:9/23/2014)... ATCC, the premier global biological materials resource and ... to the senior leadership team. Barbie Bigelow has joined ... and Dr. Maryellen de Mars also joins as the ... are new positions at ATCC. , ... described the additions as part of a revitalization strategy ...
    (Date:9/23/2014)... September 23, 2014 Follow ... gaining steady popularity the world over, due to ... Growth in the marketplace is expected to come ... in developing countries. Several sub-Saharan countries in the ... have already implemented genetically engineered crop production strategies. ...
    Breaking Biology Technology:Global Bioactive Material Market 2014-2018 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
    ... MILWAUKEE Catalyst International, a global provider of ... suite of platform-independent SCE applications. , ,"We're expanding ... customers' increasing demand for integrated fulfillment solutions from ... boundaries," said Jim Treleaven, President and CEO of ...
    ... WAUKESHA, WI. - RedPrairie Corporation , has ... electronic product code (EPC)-compliant radio frequency identification ... in a real-world environment. The RFID Lab is ... tag placement and readability as they prepare for ...
    ... supports plans for growth and strategic investments , ... and services company, today announced it has signed a ... Merchants and Manufacturers BanCorp (MMBC) , a Milwaukee-based ... credit, from which no monies have been drawn, was ...
    Cached Biology Technology:RedPrairie Builds RFID Lab - Enables Real-World Testing 2
    (Date:9/22/2014)... University researchers are studying a potential new treatment that ... in which scars develop in the lungs and severely ... miR-29, which is delivered to lung tissue intravenously. In ... reversed fibrosis after several days. , The findings ... Molecular Medicine . , "The mimic, when injected into ...
    (Date:9/22/2014)... Rochelle, NY, September 22, 2014Cassava, also known as tapioca, ... yields in areas of Africa, Asia, and Latin America ... the availability of novel enzymes and processes designed to ... be used to produce sweeteners such as glucose, fructose, ... to corn, as described in a Review article in ...
    (Date:9/22/2014)... Antarctic fishes that manufacture their own "antifreeze" ... also suffer an unfortunate side effect, researchers report: ... bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences . ... undesirable consequence of the evolution of antifreeze proteins ...
    Breaking Biology News(10 mins):Reversing the effects of pulmonary fibrosis 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3
    ... HOLLYWOOD, Calif., Aug. 20, 2012 (Pinksheets: MDBX) ( www.medboxinc.com ... 2nd quarter 2012 financials, which showed earnings of over $820,000 ... has almost doubled since the beginning of the year, and ... Medbox earns all its revenue through consulting services and the ...
    ... Southampton and the National Oceanography Centre, Southampton has found ... increase the bleaching susceptibility of reef corals. Corals ... a layer of living tissue covering the calcareous skeletons. ... within the coral polyps. The coral animal ...
    ... effort at Arizona State University to educate and train ... by the National Science Foundation (NSF). Through its Integrative ... is providing $3 million to ASU to help develop ... with the skills needed to find solutions to the ...
    Cached Biology News:Medbox, Inc. Releases 2nd Quarter Financials 2Improving water quality can help save coral reefs 2ASU awarded $3 million to research solar energy technologies, launch energy Ph.D. program 2
    ... a partial recombinant IFNA2. Immunogen: ... is produced in E. coli. The biological ... OMIM: 147562, ... MM951100564 MA Code: ABV0P9DPB ...
    Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
    Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
    Mouse monoclonal antibody raised against a full length recombinant YARS. NCBI Entrez Gene ID = YARS...
    Biology Products: